Login | Register

New Drug To Fight Against Localized High-Risk Prostate Tumors

Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial. The drug - abiraterone acetate (Zytiga(R)) - can help eliminate or almost eliminate tumors in many prostate cancer patients whose cancer has not yet metastasized...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *